An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes
Michael M. Chen, Florence Roufosse, Sa A. Wang, Srđan Verstovšek, Sandy Durrani, Marc E. Rothenberg, Thanai Pongdee, Joseph H. Butterfield, Timothy Lax, Michael E. Wechsler, Miguel Stein, Princess U. Ogbogu, Basil M. Kahwash, Sameer K. Mathur, Dagmar Simon, Praveen Akuthota, Nicole Holland, Lauren Wetzler, JeanAnne Ware, Canting Guo, Michael P. Fay, Paneez Khoury, Amy D. Klion, Bruce S. Bochner
Topics & Concepts
MepolizumabMedicineBenralizumabOmalizumabAlemtuzumabHypereosinophilic syndromeInternal medicineEosinophiliaDosingImmunologyEosinophilImmunoglobulin EAsthmaTransplantationAntibodyEosinophilic Disorders and SyndromesEosinophilic EsophagitisAsthma and respiratory diseases